SCHEMBL9301450

SCHEMBL9301450

CCOC(=O)CN1CC(O)CC1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.58
BLM P54132 1/20 0.58
GSK3A P49840 2/20 0.44
GSK3B P49841 2/20 0.44
ELANE P08246 1/20 0.41
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 3/20 0.40
PIN1 Q13526 1/20 0.40
PIN4 Q9Y237 1/20 0.40
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
FKBP1A P62942 1/20 0.38
FKBP4 Q02790 1/20 0.38
FKBP5 Q13451 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203374 1.00 APEX1 (0.58) APEX1BLMGSK3AGSK3BELANE
SCHEMBL9203370 1.00 APEX1 (0.58) APEX1BLMGSK3AGSK3BELANE
SCHEMBL11523742 0.84 APEX1 (0.47) APEX1BLMKMT2AALDH1A1ALOX15
SCHEMBL21389170 0.83 APEX1 (0.62) APEX1BLMKMT2AALDH1A1SMN1; SMN2
SCHEMBL21389109 0.83 APEX1 (0.62) APEX1BLMKMT2AALDH1A1SMN1; SMN2
SCHEMBL9301677 0.81 GSK3A (0.41) APEX1BLMGSK3AGSK3BELANE
SCHEMBL10681074 0.81 ALDH1A1 (0.43) GSK3AGSK3BELANEALDH1A1PIN1
SCHEMBL10626979 0.80 APEX1 (0.54) APEX1BLMTDP1RAB9AALDH1A1
SCHEMBL563088 0.80 GSK3A (0.41) APEX1BLMGSK3AGSK3BELANE
SCHEMBL563087 0.80 GSK3A (0.41) APEX1BLMGSK3AGSK3BELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104483400-B Method for separating and measuring oxiracetam and intermediate thereof by liquid chromatography 万全万特制药(厦门)有限公司 2020-07-31 CN claimed
CN-101914052-A Oxiracetam compound and new method thereof JIANRONG HU 2010-12-15 CN claimed
CN-111454190-A Method for synthesizing oxiracetam by adopting NaA type molecular membrane reactor 中海油天津化工研究设计院有限公司 2020-07-28 CN disclosed
CN-102846600-B Oxiracetam drug activity composition and preparation method thereof CSPC PHARMACEUTICAL GROUP OUYI PHARMA CO LTD 2015-06-17 CN disclosed
CN-102746207-B Synthesis method of oxiracetam XINTAI PHARMACEUTICAL SUZHOU CO LTD 2013-12-25 CN disclosed
CN-102846600-A Oxiracetam drug activity composition and preparation method thereof CSPC PHARMACEUTICAL GROUP OUYI PHARMA CO LTD 2013-01-02 CN disclosed
CN-102134212-A Preparation method of Oxiracetam CHONGQING SHENGHUAXI PHARMA CO 2011-07-27 CN disclosed
CN-101914052-A Oxiracetam compound and new method thereof JIANRONG HU 2010-12-15 CN disclosed
CN-1268611-C Method of preparing 4-hydroxy pyrrolidone-2-acetamine ZHANGJIAGANG HAOBO CHEMICALS C (CN) 2006-08-09 CN disclosed
CN-1513836-A Method of preparing 4-hydroxy pyrrolidone-2-acetamine 张家港浩波化学品有限公司 2004-07-21 CN disclosed
US-5371237-A Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide LONZA LTD. (CH) 1994-12-06 US disclosed
US-4824861-A Pyrrolidone derivatives and memory enhancement use thereof ISF SOCIETA PER AZIONI (IT) 1989-04-25 US disclosed
US-4824966-A Process for the production of 4-hydroxy-2-oxo-pyrrolidin-1-yl acetamide LONZA LTD. (CH) 1989-04-25 US disclosed
US-4788300-A Substituted butanamido acetate compounds for the preparation of pyrrolidone derivatives I.S.F. SOCIETA PER AZIONI (IT) 1988-11-29 US disclosed
EP-0156655-B1 PROCESS FOR THE PREPARATION OF PYRROLIDONE DERIVATIVES I.S.F. Socièta per Azioni (IT) 1988-11-23 EP disclosed
EP-0207681-A2 Pyrrolidone derivatives ISF SOCIETA PER AZIONI (IT) 1987-01-07 EP disclosed
US-4629797-A Process for the preparation of pyrrolidone derivatives I.S.F. SOCIETA PER AZIONI (IT) 1986-12-16 US disclosed
EP-0156655-A2 Process for the preparation of pyrrolidone derivatives I.S.F. Socièta per Azioni (IT) 1985-10-02 EP disclosed
US-4173569-A Preparation of pyrrolidine and pyrrolidin-2-one derivatives I.S.F. SPA (IT) 1979-11-06 US disclosed
US-4118396-A PYRROLIDIN-2-ONES, CNS AGENTS I.S.F. S.P.A. (IT) 1978-10-03 US disclosed